QUOTIENT LTD (QTNT) Stock Price, Forecast & Analysis
USA - NASDAQ:QTNT - JE00BNNSZY03 - Common Stock
QTNT Key Statistics, Chart & Performance
The current stock price of QTNT is 0.38 USD. In the past month the price decreased by -52.38%. In the past year, price decreased by -99.63%.
QTNT Latest News, Press Relases and Analysis
QTNT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 24.47 | 36.92B | ||
| COO | COOPER COS INC/THE | 17.39 | 13.90B | ||
| SOLV | SOLVENTUM CORP | 11.36 | 11.97B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.26 | 9.99B | ||
| BLCO | BAUSCH + LOMB CORP | 34.74 | 5.29B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.53 | 5.18B | ||
| LNTH | LANTHEUS HOLDINGS INC | 9.03 | 3.92B | ||
| ICUI | ICU MEDICAL INC | 15.97 | 2.97B | ||
| XRAY | DENTSPLY SIRONA INC | 7.37 | 2.52B | ||
| HAE | HAEMONETICS CORP/MASS | 10.75 | 2.41B | ||
| UFPT | UFP TECHNOLOGIES INC | 22.32 | 1.49B | ||
| ESTA | ESTABLISHMENT LABS HOLDINGS | N/A | 1.39B |
Related stock screener links
About QTNT
Company Profile
Quotient Ltd is a CH-based company operating in Health Care Equipment & Supplies industry. Quotient Limited is a Switzerland-based diagnostics company. The firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. The company is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company is engaged in developing MosaiQ, which is its technology platform. The firm develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
Company Info
QUOTIENT LTD
B1, Business Park Terre Bonne, Route de Crassier 13, Eysins
VAUD 1262 CH
CEO: Manuel O. Mendez
Employees: 450
Phone: 41227169800.0
QUOTIENT LTD / QTNT FAQ
Can you describe the business of QUOTIENT LTD?
Quotient Ltd is a CH-based company operating in Health Care Equipment & Supplies industry. Quotient Limited is a Switzerland-based diagnostics company. The firm focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. The company is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company is engaged in developing MosaiQ, which is its technology platform. The firm develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).
What is the stock price of QUOTIENT LTD today?
The current stock price of QTNT is 0.38 USD. The price increased by 2.73% in the last trading session.
Does QUOTIENT LTD pay dividends?
QTNT does not pay a dividend.
How is the ChartMill rating for QUOTIENT LTD?
QTNT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting QTNT stock to perform?
7 analysts have analysed QTNT and the average price target is 61.2 USD. This implies a price increase of 16005.26% is expected in the next year compared to the current price of 0.38.
QTNT Technical Analysis
QTNT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to QTNT. QTNT has a bad profitability rating. Also its financial health evaluation is rather negative.
QTNT Financial Highlights
Over the last trailing twelve months QTNT reported a non-GAAP Earnings per Share(EPS) of -53.21. The EPS decreased by -11.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
QTNT Forecast & Estimates
7 analysts have analysed QTNT and the average price target is 61.2 USD. This implies a price increase of 16005.26% is expected in the next year compared to the current price of 0.38.
For the next year, analysts expect an EPS growth of 44.75% and a revenue growth 6.8% for QTNT